1. Home
  2. PXLW vs VERU Comparison

PXLW vs VERU Comparison

Compare PXLW & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pixelworks Inc.

PXLW

Pixelworks Inc.

HOLD

Current Price

$7.06

Market Cap

42.7M

Sector

Technology

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.33

Market Cap

39.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXLW
VERU
Founded
1997
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.7M
39.8M
IPO Year
2000
1990

Fundamental Metrics

Financial Performance
Metric
PXLW
VERU
Price
$7.06
$2.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$14.33
$25.00
AVG Volume (30 Days)
102.2K
197.2K
Earning Date
02-11-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,205,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.67
$2.10
52 Week High
$15.42
$14.20

Technical Indicators

Market Signals
Indicator
PXLW
VERU
Relative Strength Index (RSI) 55.84 45.87
Support Level $6.13 $2.10
Resistance Level $6.84 $2.38
Average True Range (ATR) 0.41 0.18
MACD 0.08 0.02
Stochastic Oscillator 85.04 44.00

Price Performance

Historical Comparison
PXLW
VERU

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Share on Social Networks: